Cibus, Inc. Files Definitive Proxy Statement (DEF 14A)

TL;DR

<b>Cibus, Inc. has filed its Definitive Proxy Statement (DEF 14A) for the period ending May 30, 2024.</b>

AI Summary

Cibus, Inc. (CBUS) filed a Proxy Statement (DEF 14A) with the SEC on April 19, 2024. Cibus, Inc. filed a Definitive Proxy Statement (DEF 14A) on April 19, 2024. The filing covers the period ending May 30, 2024. The company's principal executive offices are located at 6455 Nancy Ridge Drive, San Diego, CA 92121. Cibus, Inc. was formerly known as Calyxt, Inc. until May 4, 2017. The SIC code for Cibus, Inc. is 2870 (AGRICULTURE CHEMICALS).

Why It Matters

For investors and stakeholders tracking Cibus, Inc., this filing contains several important signals. This filing is crucial for shareholders to understand executive compensation, board nominations, and other corporate governance matters before the annual meeting. The DEF 14A provides detailed information on the company's financial performance and strategic direction, which can influence investment decisions.

Risk Assessment

Risk Level: low — Cibus, Inc. shows low risk based on this filing. The filing is a routine DEF 14A, indicating standard corporate governance procedures rather than immediate financial distress or significant operational changes.

Analyst Insight

Review the executive compensation details and any proposed shareholder resolutions to assess management alignment and potential governance changes.

Key Numbers

• 2024-04-19 — Filing Date (DEF 14A filing date)
• 2024-05-30 — Period of Report (Conformed period of report)
• 2870 — SIC Code (Standard Industrial Classification for Agriculture Chemicals)
• DE — State of Incorporation (State of incorporation)
• 1231 — Fiscal Year End (Fiscal year end)

Key Players & Entities

• Cibus, Inc. (company) — Filer name
• DEF 14A (filing) — Form type
• 2024-04-19 (date) — Filing date
• 2024-05-30 (date) — Reporting period end date
• 6455 Nancy Ridge Drive, San Diego, CA 92121 (address) — Business address
• Calyxt, Inc. (company) — Former company name
• 2870 (sic_code) — Standard Industrial Classification
• 0001705843 (cik) — Central Index Key

FAQ

Industry Context

Cibus, Inc. operates in the agriculture chemicals sector, focusing on agricultural biotechnology.

Regulatory Implications

The filing is a standard DEF 14A, subject to SEC regulations for public companies regarding disclosure of corporate actions and governance.

What Investors Should Do

1. Analyze the proposals being put forth for shareholder vote.
2. Review the compensation details for named executive officers.
3. Examine the director nominees and their qualifications.

Key Dates

• 2024-04-19: Filing of DEF 14A — Indicates the company is providing formal disclosure on corporate matters.

Year-Over-Year Comparison

This is the initial DEF 14A filing for Cibus, Inc. under its current structure and name, following its former identity as Calyxt, Inc.

Key Financial Figures

• $0 — hare of Class A Common Stock, par value $0.0001, or Class B Common Stock, par valu
• $0.0001 — Legacy Calyxt's common stock, par value $0.0001 per share (" Legacy Common Stock ") and

Filing Documents

• cbus-20240419.htm (DEF 14A) — 637KB
• cbus-20240419_g1.jpg (GRAPHIC) — 33KB
• cbus-20240419_g2.jpg (GRAPHIC) — 61KB
• cbus-20240419_g3.jpg (GRAPHIC) — 62KB
• cbus-20240419_g4.jpg (GRAPHIC) — 8KB
• cbus-20240419_g5.jpg (GRAPHIC) — 10KB
• 0001628280-24-016939.txt (&nbsp;) — 1791KB
• cbus-20240419.xsd (EX-101.SCH) — 4KB
• cbus-20240419_def.xml (EX-101.DEF) — 6KB
• cbus-20240419_lab.xml (EX-101.LAB) — 7KB
• cbus-20240419_pre.xml (EX-101.PRE) — 4KB
• cbus-20240419_htm.xml (XML) — 160KB

Executive Compensation

Executive Compensation 19 Director Compensation 30 Proposal No. 2 — Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers 31 Proposal No. 3 — Ratification of Appointment of Independent Registered Public Accounting Firm 32 Relationship with Independent Registered Public Accounting Firm 32 Report of the Audit Committee 34

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 35 Delinquent Section 16(a) Reports 38 Certain Relationships and Related Transactions 38 Other Matters 42 Table of Contents EXPLANATORY NOTE Terms When the terms " Cibus ," the " Company ," " we ," " us ," " our " or " its " are used in this Proxy Statement, unless the context otherwise requires, those terms are being used to refer to Cibus, Inc. (formerly Calyxt, Inc.) and its consolidated subsidiaries (i) excluding Cibus Global, LLC and its consolidated subsidiaries, prior to the completion of the Merger Transactions (as defined below under the heading "—Completion of Merger Transactions") and (ii) the combined entity, including Cibus Global, LLC and its consolidated subsidiaries, as of and following the consummation of the Merger Transactions. When the term " Legacy Calyxt " is used, it is being used to exclusively refer to Calyxt, Inc. prior to the Merger Transactions. When the term " Cibus Global " is used, it is being used to refer to Cibus Global, LLC, both prior to and after the completion of the Merger Transactions. When the term " Cellectis " is used, it is being used to refer to Cellectis S.A. ( socit anonyme ), the Company's largest shareholder prior to the completion of the Merger Transactions. When the term " Class A Common Stock " is used, it is being used, unless the context requires otherwise, to refer prior to the Merger Transactions to Legacy Calyxt's common stock, par value $0.0001 per share (" Legacy Common Stock ") and following the Merger Transactions to the Class A Common Stock, $0.0001 par value per share. Each share of Legacy Common Stock existing and outstanding immediately prior to the Merger Transactions remained outstanding as a share of Class A Common Stock without any conversion or exchange thereof. The Company owns or has the right to use the trademarks, service marks, and trade names that it uses in conjunction with the operation of its business. Som

View Full Filing

View this DEF 14A filing on SEC EDGAR